Practical application of guinea pig telemetry system for QT evaluation

Journal of Toxicological Sciences

Volumn 30, Issue 3, 2005, Pages 239-247

  Shiotani, Motohiro ^a   Harada, Takuma ^a   Abe, Junko ^a   Sawada, Yasufusa ^b   Hashimoto, Keitaro ^c   Hamada, Yoshimasa ^a   Horii, Ikuo ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Pfizer Japan Inc   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Guinea pig; In vivo; Qt interval; QTc; Telemetry system

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; BEPRIDIL; CISAPRIDE; HALOPERIDOL; NIFEDIPINE; PIMOZIDE; PROPRANOLOL DERIVATIVE; QUINIDINE; TERFENADINE; THIORIDAZINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SIZE; CONTROLLED STUDY; GUINEA PIG; HYSTERESIS; MALE; NONHUMAN; QT INTERVAL; QT PROLONGATION; RR INTERVAL; T WAVE; TELEMETRY;

ANIMALIA; CAVIA; CAVIA PORCELLUS;

EID: 24944538435     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.30.239     Document Type: Article

References (33)

1. Akita, M., Ishii, K., Kuwahara, M. and Tsubone, H. (2001): The Daily Pattern of Heart Rate, Body Temperature, and Locomotor Activity in Guinea Pigs. Exp. Anim., 50, 409-415.
2. Bazett, H.C. (1920): An analysis of the time-relations of electrocardiograms. Heart, 7, 353-370.
3. Chiang, C.E., Luk, H.N., Wang, T.M. and Ding, P.Y. (2002): Effects of sildenafil on cardiac repolarization. Cardiovasc. Res., 55, 290-299.
4. De Abajo, F.J. and Rodriguez, L.A. (1999): Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br. J. Clin. Pharmacol., 47, 307-313.
5. De Clerck, F., van de Water, A., D'Aubioul, J., Lu, H.R., van Rossem, K., Hermans, A. and van Ammel, K. (2002): In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: Application to the preclinical cardiovascular safety pharmacology of a new chemical entity. Fundam. Clin. Pharmacol., 16, 125-140.
6. Douglas, P.H. and Block, P.C. (2000): Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes. Catheter. Cardiovasc. Interv., 50, 352-355.
7. Farkas, A., Lepran, I. and Papp, J.G. (2002): Proarrhythmic effects of intravenous quinidine, amiodarone, d-sotalol, and almokalant in the anesthetized rabbit model of Torsade de Pointes. J. Cardiovasc. Pharmacol., 39, 287-297.
8. Fridericia, L.S. (1920): Die Systolendauer im Elektrokardiogramm bei normaln Menschen und bei Herzkranken. Acta. Med. Scan., 53, 469.
9. 1-antihistamines in a guinea-pig model of arrhythmogenicity. Br. J. Pharmacol., 119, 187-188.
10. Hamlin, R.L., Kijtawornrat, A., Keene, B.W. and Hamlin, D.M. (2003): QT and RR Intervals in Conscious and Anesthetized Guinea Pigs with Highly Varying RR Intervals and Given QTc-Lengthening Test Articles. Toxicol. Sci., 76, 437-442.
11. Harada, T., Hassimoto, M., Mitsui, T., Kaga, N., Obata, M. and Mochizuki, H. (2002): Long-term Observation of Electrocardiographic Changes in Thyroidectomized Male Rats. Adv. Anim. Cardiol., 35, 13-24.
12. Hassaballa, H.A. and Balk, R.A. (2003): Torsade de pointes associated with the administration of intravenous haloperidol: A review of the literature and practical guidelines for use. Expert. Opin. Drug. Saf., 2, 543-547.
13. Hatta, K., Takahashi, T., Nakamura, H., Yamashiro, H., Asukai, N., Matsuzaki, I. and Yonezawa, Y. (2001): The association between intravenous haloperidol and prolonged QT interval. J. Clin. Psychopharmacol., 21, 257-261.
14. Hayes, E., Pugsley, K.M., Penz, P.W., Adaikan, G. and Walker, J.M. (1994): Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. J. Pharmacol. Toxicol. Methods, 32, 201-207.
15. Hill, S.L., Evangelista, J.K., Pizzi, A.M., Mobassaleh, M., Fulton, D.R. and Berul, C.I. (1998): Proarrhythmia associated with cisapride in children. Pediatrics, 101, 1053-1056.
16. Horii, I., Kito, G., Hamada, T., Jikuzono, T., Kobayashi, K. and Hashimoto, K. (2002): Development of telemetry system in the common marmoset -Cardiovascular effects of astemizole and nicardipine. J. Toxicol. Sci., 27, 123-130.
17. Hunt, N. and Stern, T.A. (1995): The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review. Psychosomatics, 36, 541-549.
18. JIS (1965): The t-test with F-test for homogeneity of variance. Significance test of difference between the two population means (standard deviations unknown, two-sided). Japanese Industry Standard Z9049.
19. 4 Receptor Agonists, Cisapride and Mosapride Citrate on Electrocardiogram in Anaesthetized Rats and Guinea-Pigs and Conscious Cats. Pharmacol. Toxicol., 89, 96-103.
20. Matsunaga, T., Mitsui, T., Harada, T., Inokuma, M., Murano, H. and Shibutani, Y. (1997): QT Corrected for Heart Rate and Relation Between QT and RR Intervals in Beagle Dogs. J. Pharmacol. Toxicol. Methods., 38, 201-209.
21. Metzger, E. and Friedman, R. (1993): Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J. Clin. Psychopharmacol., 13, 128-132.
22. Minematsu, T., Ohtani, H., Yamada, Y., Sawada, Y., Sato, H. and Iga, T. (2001): Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: Pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect. J. Pharmacokinet. Pharmacodyn., 28, 533-554.
23. + channel diversity in the mammalian myocardium. J. Physiol., 525, 285-298.
24. Ohmura, T., Chachin, M., Tarui, S., Nagakura, A., Igarashi, T., Ikeda, H., Ikegami, K., Kitagawa, H. and Uchida, S. (1999): Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys. Eur. J. Pharmacol., 378, 169-175.
25. Ohtani, H., Odagiri, Y., Sato, H., Sawada, Y. and Iga, T. (2001): A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs. Biol. Pharm. Bull., 24, 550-554.
26. Picard, S. and Lacroix, P. (2003): QT interval prolongation and cardiac risk assessment for novel drugs. Curr. Opin. Investig. Drugs., 4, 303-308.
27. Shah, R.R. (2002): The significance of QT interval in drug development. Br. J. Clin. Pharmacol., 54, 188-202.
28. Tashibu, H. (2004): QT Interval Prolongation: Project for Database Construction, 4) Overview of anesthetized dog studies. J. Toxicol. Sci., 29, 365.
29. Tisdale, J.E., Rasty, S., Padhi, I.D., Sharma, N.D. and Rosman, H. (2001): The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes. J. Clin. Pharmacol., 41, 1310-1318.
30. Toyoshima, S. (2004): QT interval prolongation: Project for database construction, 2) Overview of dog telemetry studies. J. Toxicol. Sci., 29, 363.
31. Welch, B.L. (1938): The significance of the difference between two means when the population variances are unequal. Biometrika, 29, 350-362.
32. Woosley, R.L., Chen, Y., Freiman, J.P. and Gillis, R.A. (1993): Mechanism of the cardiotoxic actions of terfenadine. JAMA, 269, 1532-1536.
33. Yoshida, H., Sugiyama, A., Satoh, Y., Ishida, Y., Yoneyama, M., Kugiyama, K. and Hashimoto, K. (2002): Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. Circ. J., 66, 758-762.